Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Liang-Wen Hang, Jeng-Yuan Hsu, Chee-Jen Chang, Hao-Chien Wang, Shih-Lung Cheng, Ching-Hsiung Lin, Ming-Cheng Chan, Chin-Chou Wang, Diahn-Warng Perng & Chong-Jen Yu. (2016) Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 665-673.
Read now
Read now
Tsuyoshi Tanabe, Henry J Rozycki, Soichiro Kanoh & Bruce K Rubin. (2012) Cardiac asthma: new insights into an old disease. Expert Review of Respiratory Medicine 6:6, pages 705-714.
Read now
Read now
Alan J Crockett & David Price. (2007) Co-morbid disease in COPD – more than a coincidence. International Journal of Chronic Obstructive Pulmonary Disease 2:4, pages 399-400.
Read now
Read now
Articles from other publishers (27)
Hong Chen, Xiaojia Luo, Yuejun Du, Chenyun He, Yanjun Lu, Zixuan Shi & Jin Zhou. (2023) Association between chronic obstructive pulmonary disease and cardiovascular disease in adults aged 40 years and above: data from NHANES 2013–2018. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Panaiotis Finamore, Luigi Tanese, Filippo Longo, Domenico De Stefano, Claudio Pedone, Laura Angelici, Nera Agabiti, Silvia Cascini, Marina Davoli, Bruno Beomonte Zobel, Raffaele Antonelli Incalzi & Pierfilippo Crucitti. (2022) The additional value of lung cancer screening program in identifying unrecognized diseases. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Mariya Marushchak, Khrystyna Maksiv, Inna Krynytska & Kateryna Kozak. (2019) Association between arterial hypertension and chronic obstructive pulmonary disease: role of AGT gene polymorphism. Pneumologia 68:4, pages 174-182.
Crossref
Crossref
Kh. Ya. Maksiv & M. I. Marushchak. (2019) КОМОРБІДНІСТЬ ХРОНІЧНОГО ОБСТРУКТИВНОГО ЗАХВОРЮВАННЯ ЛЕГЕНЬ З АРТЕРІАЛЬНОЮ ГІПЕРТЕНЗІЄЮ: СТАН СИСТЕМИ АНТИОКСИДАНТНОГО ЗАХИСТУ. Вісник медичних і біологічних досліджень:1, pages 35-40.
Crossref
Crossref
Damilya Nugmanova, Yuriy Feshchenko, Liudmyla Iashyna, Olga Gyrina, Kateryna Malynovska, Eljan Mammadbayov, Irada Akhundova, Nadezhda Nurkina, Luqman Tariq, Janina Makarova & Averyan Vasylyev. (2018) The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study. BMC Pulmonary Medicine 18:1.
Crossref
Crossref
Julia Shanks, Zhiqiu Xia, Steven J. Lisco, George J. Rozanski, Harold D. Schultz, Irving H. Zucker & Han-Jun Wang. (2018) Sympatho-excitatory response to pulmonary chemosensitive spinal afferent activation in anesthetized, vagotomized rats. Physiological Reports 6:12, pages e13742.
Crossref
Crossref
Sai Krishna C. Korada, Di Zhao, Martin Tibuakuu, Todd T. Brown, Lisa P. Jacobson, Eliseo Guallar, Robert K. Bolan, Frank J. Palella, Joseph B. Margolick, Jeremy J. Martinson, Matthew J. Budoff, Wendy S. Post & Erin D. Michos. (2017) Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS). Atherosclerosis 266, pages 240-247.
Crossref
Crossref
Ha Ryong Kim, Han Soo Cho, Da Young Shin & Kyu Hyuck Chung. (2017) Novel approach to study the cardiovascular effects and mechanism of action of urban particulate matter using lung epithelial-endothelial tetra-culture system. Toxicology in Vitro 38, pages 33-40.
Crossref
Crossref
Roland Buhl, Sheldon Magder, Ulrich Bothner, Kay Tetzlaff, Florian Voß, Lazaro Loaiza, Claus F. Vogelmeier & Lorcan McGarvey. (2017) Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease. Respiratory Medicine 122, pages 58-66.
Crossref
Crossref
Reza Karbasi-Afshar, Mahyar Mohammadifard, Nahid Azdaki, Parvin Rahnama, Amin Saburi & Mostafa Ghanei. (2016) Sulfur Mustard Exposure and Cardiovascular Effects: A Review. Trauma Monthly 22:2.
Crossref
Crossref
P. Padmini S.J. Khedoe, Patrick C.N. Rensen, Jimmy F.P. Berbée & Pieter S. Hiemstra. (2016) Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology 310:11, pages L1011-L1027.
Crossref
Crossref
P. D. Loprinzi & J. F. Walker. (2016) Increased daily movement associates with reduced mortality among COPD patients having systemic inflammation. International Journal of Clinical Practice 70:3, pages 286-291.
Crossref
Crossref
Giuseppe Sergi, Nicola Veronese, Luigi Fontana, Marina De Rui, Francesco Bolzetta, Sabina Zambon, Maria-Chiara Corti, Giovannella Baggio, Elena Debora Toffanello, Gaetano Crepaldi, Egle Perissinotto & Enzo Manzato. (2015) Pre-Frailty and Risk of Cardiovascular Disease in Elderly Men and Women. Journal of the American College of Cardiology 65:10, pages 976-983.
Crossref
Crossref
Cristina Andreoli, Antonella Bassi, Evan O. Gregg, Alfredo Nunziata, Riccardo Puntoni & Emanuela Corsini. (2015) Effects of cigarette smoking on circulating leukocytes and plasma cytokines in monozygotic twins. Clinical Chemistry and Laboratory Medicine (CCLM) 53:1.
Crossref
Crossref
Marietta Rottenkolber, Dominik Rottenkolber, Rainald Fischer, Luisa Ib??ez, Joan Fortuny, Elena Ballarin, Monica Sabat?Pili Ferrer, Petra Th?rmann, Joerg Hasford & Sven Schmiedl. (2014) Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients. Respiratory Medicine 108:8, pages 1075-1090.
Crossref
Crossref
Pontus Andell, Sasha Koul, Andreas Martinsson, Johan Sundstr?m, Tomas Jernberg, J Gustav Smith, Stefan James, Bertil Lindahl & David Erlinge. (2014) Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart 1:1, pages e000002.
Crossref
Crossref
Wanzhen Yao. (2014) Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease. Medical Science Monitor 20, pages 311-320.
Crossref
Crossref
Florent Baty, Paul Martin Putora, Bruno Isenring, Torsten Blum & Martin Brutsche. (2013) Comorbidities and Burden of COPD: A Population Based Case-Control Study. PLoS ONE 8:5, pages e63285.
Crossref
Crossref
Jacob N. de Voogd, Johan B. Wempe, Klaas Postema, Eric van Sonderen, Adelita V. Ranchor, James C. Coyne & Robbert Sanderman. (2009) More Evidence that Depressive Symptoms Predict Mortality in COPD Patients: Is Type D Personality an Alternative Explanation?. Annals of Behavioral Medicine 38:2, pages 86-93.
Crossref
Crossref
C Lambers, S Hacker, M Posch, K Hoetzenecker, A Pollreisz, M Lichtenauer, W Klepetko & H Jan Ankersmit. (2009) T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease. Clinical and Experimental Immunology 155:3, pages 466-475.
Crossref
Crossref
José M. Baena-Díez, Rafael Ramos & Jaume Marrugat. (2009) Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades. Revista Española de Cardiología Suplementos 9:2, pages 4-13.
Crossref
Crossref
David M.G. Halpin, Stefan Peterson, Thomas P. Larsson & Peter M.A. Calverley. (2008) Identifying COPD patients at increased risk of mortality: Predictive value of clinical study baseline data. Respiratory Medicine 102:11, pages 1615-1624.
Crossref
Crossref
A. I. Blamoun, G. N. Batty, V. A. DeBari, A. O. Rashid, M. Sheikh & M. A. Khan. (2008) Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. International Journal of Clinical Practice 62:9, pages 1373-1378.
Crossref
Crossref
A. Cuvelier. (2008) Exacerbations de la BPCO. Revue des Maladies Respiratoires 25, pages 22-31.
Crossref
Crossref
David Hiestand & Barbara Phillips. (2008) The Overlap Syndrome: Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea. Critical Care Clinics 24:3, pages 551-563.
Crossref
Crossref
S. N. Avdeev & G. E. Baymakanova. (2008) COPD and cardiovascular diseases: mechanisms of association. PULMONOLOGIYA:1, pages 5-13.
Crossref
Crossref
Gillian M Keating & Paul L McCormack. (2007) Salmeterol/Fluticasone Propionate. Drugs 67:16, pages 2383-2405.
Crossref
Crossref